BAI RUI KANG (GUANGZHOU) CELL MEDICINE TECHNOLOGY CO LTD
Overview
BAI RUI KANG (GUANGZHOU) CELL MEDICINE TECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering HUMAN PLATELET LYSATE.
API / Drug Master Files
BAI RUI KANG (GUANGZHOU) CELL MEDICINE TECHNOLOGY CO LTD holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- HUMAN PLATELET LYSATEActive2025-02-09
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to BAI RUI KANG (GUANGZHOU) CELL MEDICINE TECHNOLOGY CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.